BVF Partners OS Ltd Net Worth - Insider Trades and Bio as of Jun 19, 2026

Repare Therapeutics Inc.SEC CIK: 0001660684

Estimated Net Worth

$617 Million

Last Updated: May 19, 2026 11:43 PM EST

Transaction Summary

Total Transactions225

Buy-Sell Ratio4.64

Buy Transactions116

Sell Transactions25

Transaction Volume

Total Volume-$365.13M

Net Volume$1.35B

Buy Volume$490.80M

Sell Volume-$855.93M

Trade Analysis

AVG Trade Size-$1.75M

Largest Trade$25.58M

Most Active MonthJun

Most Active Year2020

Trading Sentiment

OverallBullish

Recent TradeSelling

Last 90 Days-1 Trades

ConvictionMedium

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

BVF Partners OS Ltd. has an estimated net worth of $617 Million. This is based on reported shares across multiple companies, which include Allakos Inc., Rain Oncology Inc., IMMUNE DESIGN CORP., Cascadian Therapeutics, Inc., XOMA Royalty Corp, Xenon Pharmaceuticals Inc., Cullinan Oncology, Inc., Merus N.V., Nivalis Therapeutics, Inc., Repare Therapeutics Inc., PALVELLA THERAPEUTICS, INC., Verastem, Inc., Syndax Pharmaceuticals Inc, CTI BIOPHARMA CORP, IDEAYA Biosciences, Inc., CYTOKINETICS INC, Kymera Therapeutics, Inc., Calithera Biosciences, Inc., CONCERT PHARMACEUTICALS, INC., CytomX Therapeutics, Inc., MoonLake Immunotherapeutics, GLYCOMIMETICS INC, Principia Biopharma Inc., INFINITY PHARMACEUTICALS, INC., Eledon Pharmaceuticals, Inc., Olema Pharmaceuticals, Inc., Regulus Therapeutics Inc., ESSA Pharma Inc., 4D Molecular Therapeutics, Inc., Third Harmonic Bio, Inc., FIVE PRIME THERAPEUTICS, INC., Structure Therapeutics Inc., ARQULE INC, enGene Holdings Inc., POINT Biopharma Global Inc., and IMMUNIC, INC..

2020 was BVF Partners OS Ltd.'s most active year for acquiring shares with 122 total transactions. BVF Partners OS Ltd.'s most active month to acquire stocks was the month of April. 2020 was BVF Partners OS Ltd.'s most active year for disposing of shares, totalling 39 transactions. BVF Partners OS Ltd.'s most active month to dispose stocks was the month of May. 2021 saw BVF Partners OS Ltd. paying a total of $132,144,944.64 for 12,405,370 shares, this is the most they've acquired in one year. In 2023 BVF Partners OS Ltd. cashed out on 40,301,603 shares for a total of $294,248,967.10, their largest year based on trade value.

Holdings & Transactions

RPTXrepare therapeutics inc.

Updated: Jan 30, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	10.17M	—	—	Jan 30, 2026	—	Disposition	—	Jan 28	View
From 4	0.07	1.23M	$5.19	$6.25M	Nov 17, 2023	20.04M	Purchase	—	Nov 15 - 16	View
From 4	0.10	783.71K	$3.60	$2.82M	Nov 03, 2023	8.94M	Purchase	—	Nov 02	View
From 4	0.02	149.16K	$12.73	$1.90M	Jun 15, 2022	8.16M	Purchase	—	Jun 13	View
From 4	0.30	1.84M	$11.90	$21.86M	Jun 06, 2022	8.01M	Purchase	—	Jun 02 - 06	View
From 4	0.07	420.00K	$8.50	$3.57M	May 20, 2022	6.17M	Purchase	—	May 18	View
From 4	0.21	997.96K	$14.10	$14.07M	Jan 21, 2022	5.75M	Purchase	—	Jan 19	View
From 3	—	—	—	—	Nov 08, 2021	4.75M	—	—	—	View

MLTXmoonlake immunotherapeutics

Updated: Apr 02, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.19	3.75M	$16.79	-$62.96M	Apr 02, 2026	15.97M	Sale	—	Mar 31	View
From 4	—	6.68K	—	—	Jun 09, 2025	19.72M	Grant	—	Jun 05	View
From 4	-0.09	2.00M	$50.00	-$100.00M	Oct 08, 2024	19.71M	Sale	—	Oct 04	View
From 4	—	7.69K	—	—	Jun 10, 2024	21.71M	Grant	—	Jun 06	View
From 4	—	11.30K	—	—	Jun 12, 2023	21.70M	Grant	—	Jun 08	View
From 3	—	—	—	—	Apr 15, 2022	21.69M	—	—	—	View

IMUXimmunic, inc.

Updated: Feb 27, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 27, 2026	7.59M	—	—	—	View

allakos inc.

Updated: May 19, 2025

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	16.31M	—	—	May 19, 2025	—	Disposition	—	May 15	View
From 3	—	—	—	—	Jan 26, 2024	16.31M	—	—	—	View

XOMAxoma royalty corp

Updated: May 20, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.13	392.72K	$27.10	-$10.64M	May 20, 2025	2.60M	Sale	—	May 16	View
From 4	-0.18	650.72K	$26.10	-$16.98M	Jan 28, 2025	2.99M	Sale	—	Jan 24	View
From 4	—	10.97K	—	—	May 19, 2023	3.91M	Grant	—	May 17	View
From 4	0.01	22.25K	$19.15	$420.74K	Jan 09, 2023	3.90M	Purchase	—	Jan 05 - 06	View
From 4	0.01	24.64K	$16.61	$409.31K	Sep 27, 2022	3.88M	Purchase	—	Sep 23 - 27	View
From 4	0.02	56.31K	$17.70	$990.72K	Sep 16, 2022	3.85M	Purchase	—	Sep 14 - 16	View
From 4	—	9.00K	—	—	May 20, 2022	3.80M	Grant	—	May 18	View
From 4	—	5.10K	—	—	May 21, 2021	3.79M	Grant	—	May 19	View
From 4	-0.16	651.70K	$38.36	-$25.00M	Apr 02, 2021	3.78M	Sale	—	Mar 31	View
From 4	—	200.00K	$25.00	$5.00M	Dec 15, 2020	4.43M	Purchase	—	Dec 11	View
From 4	0.01	51.37K	$18.34	$941.96K	Sep 23, 2020	4.23M	Purchase	—	Sep 21 - 23	View
From 4	0.00	7.74K	$18.77	$145.23K	Sep 10, 2020	4.18M	Purchase	—	Sep 04	View
From 4	0.01	35.62K	$18.71	$666.48K	Sep 01, 2020	4.16M	Purchase	—	Aug 28 - 01	View
From 4	0.01	28.18K	$19.41	$546.65K	Aug 25, 2020	4.13M	Purchase	—	Aug 21 - 25	View
From 4	0.00	6.16K	$19.47	$120.00K	Aug 20, 2020	4.06M	Purchase	—	Aug 18 - 20	View
From 4	0.01	27.02K	$18.46	$498.74K	Aug 14, 2020	4.06M	Purchase	—	Aug 12 - 14	View
From 4	0.53	1.25M	$13.00	$16.29M	Apr 17, 2020	4.03M	Options	—	Apr 15	View
From 4	0.01	8.26K	$17.20	$142.13K	Mar 27, 2020	2.78M	Purchase	—	Mar 25	View
From 4	0.00	4.44K	$14.52	$64.47K	Mar 20, 2020	2.77M	Purchase	—	Mar 18	View
From 4	0.10	118.28K	$17.94	$2.12M	Mar 17, 2020	2.77M	Purchase	—	Mar 13 - 17	View
From 4	0.10	373.19K	$22.00	$18.60M	Dec 20, 2019	4.53M	Purchase	—	Dec 18 - 19	View
From 4	0.04	27.91K	$14.63	$408.23K	May 14, 2019	1.80M	Purchase	—	May 10 - 14	View
From 4	0.04	25.68K	$28.63	$406.79K	Dec 19, 2018	1.78M	Purchase	—	Dec 14 - 18	View
From 4	0.06	36.46K	$14.46	$527.24K	Dec 13, 2018	1.75M	Purchase	—	Dec 11 - 13	View
From 4	0.10	61.02K	$14.71	$897.45K	Dec 10, 2018	1.71M	Purchase	—	Dec 06 - 10	View
From 4	0.02	9.80K	$14.91	$146.14K	Dec 04, 2018	1.65M	Purchase	—	Nov 30 - 04	View
From 4	0.05	29.70K	$15.10	$448.48K	Nov 29, 2018	1.64M	Purchase	—	Nov 27 - 29	View
From 4	0.15	72.25K	$14.17	$1.02M	Nov 21, 2018	1.61M	Purchase	—	Nov 19 - 21	View
From 4	0.07	31.99K	$13.48	$431.35K	Nov 19, 2018	1.54M	Purchase	—	Nov 15 - 16	View
From 3	—	—	—	—	Feb 21, 2017	1.50M	—	—	—	View

KYMRkymera therapeutics, inc.

Updated: Jul 01, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.07	333.17K	$44.00	$13.96M	Jul 01, 2025	6.83M	Purchase	—	Jun 25 - 30	View
From 4	—	358.29K	$40.75	$14.60M	Aug 22, 2024	6.49M	Purchase	—	Aug 20	View
From 4	—	16.00K	—	—	Jun 28, 2024	6.13M	Grant	—	Jun 18	View
From 4	—	979.01K	$25.25	$24.72M	Jan 09, 2024	6.12M	Purchase	—	Jan 05	View
From 4	0.04	414.11K	$12.85	$5.30M	Nov 06, 2023	10.00M	Purchase	—	Nov 02 - 03	View
From 4	—	12.00K	—	—	Jun 20, 2023	4.72M	Grant	—	Jun 15	View
From 4	0.00	41.01K	$30.57	$1.25M	Jan 13, 2023	9.08M	Purchase	—	Jan 11 - 12	View
From 4	0.13	545.52K	$26.00	$14.18M	Aug 23, 2022	4.67M	Purchase	—	Aug 22	View
From 4	—	12.00K	—	—	Jun 17, 2022	4.13M	Grant	—	Jun 15	View
From 4	0.08	289.43K	$14.34	$4.15M	May 31, 2022	4.11M	Purchase	—	May 26 - 27	View
From 4	0.00	10.10K	$14.00	$141.39K	May 24, 2022	3.83M	Purchase	—	May 20	View
From 4	0.07	250.00K	$19.45	$4.87M	May 09, 2022	3.81M	Purchase	—	May 05 - 06	View
From 4	0.04	130.31K	$38.96	$5.08M	Jan 31, 2022	3.56M	Purchase	—	Jan 27 - 31	View
From 4	0.09	272.77K	$37.76	$10.30M	Jan 26, 2022	3.43M	Purchase	—	Jan 24	View
From 4	0.21	544.17K	$47.00	$25.58M	Jul 06, 2021	3.16M	Purchase	—	Jul 01	View
From 4	—	20.06K	—	—	Jun 21, 2021	2.62M	Grant	—	Jun 16	View
From 4	-0.00	661.00	$20.00	—	Aug 25, 2020	2.60M	Options	—	Aug 20 - 21	View
From 3	—	—	—	—	Aug 25, 2020	—	—	—	—	View

CBIOglycomimetics inc

Updated: Jun 17, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	19.92	1.86M	—	—	Jun 17, 2025	1.95M	Acquisition	—	Jun 13	View
From 4	0.16	1.27M	$2.60	$3.29M	Nov 06, 2020	9.32M	Purchase	—	Nov 04	View
From 4	0.13	932.61K	$2.75	$2.56M	Nov 03, 2020	8.06M	Purchase	—	Oct 30	View
From 4	0.31	1.67M	$3.18	$5.31M	Sep 09, 2019	7.12M	Purchase	—	Sep 05	View
From 3	—	—	—	—	Aug 26, 2019	5.46M	—	—	—	View
From 3	—	—	—	—	May 11, 2017	3.02M	—	—	—	View

OLMAolema pharmaceuticals, inc.

Updated: Jun 13, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	24.15K	—	—	Jun 13, 2025	11.54M	Grant	—	Jun 11	View
From 4	—	—	—	—	Jan 14, 2025	11.51M	Acq/Dis	—	Jan 10	View
From 4	0.20	2.47M	$9.08	$22.38M	Dec 04, 2024	14.88M	Acquisition	—	Dec 04	View
From 4	—	23.00K	—	—	Jun 18, 2024	9.05M	Grant	—	Jun 14	View
From 4	0.22	1.61M	$9.84	$14.82M	Sep 14, 2023	9.03M	Purchase	—	Sep 12 - 14	View
From 4	—	21.52K	—	—	Jun 21, 2023	7.42M	Grant	—	Jun 16	View
From 4	0.03	200.00K	$4.03	$806.90K	Jun 14, 2022	7.38M	Purchase	—	Jun 10	View
From 4	0.12	739.67K	$9.39	$6.95M	Dec 02, 2021	7.18M	Purchase	—	Nov 30	View
From 4	—	99.56K	—	—	May 26, 2021	6.52M	Acq/Dis	—	Mar 31	View
From 4	0.23	1.20M	$19.00	—	Nov 20, 2020	6.42M	Purchase	—	Nov 18 - 19	View
From 3	—	—	—	—	Nov 19, 2020	—	—	—	—	View

EPIXessa pharma inc.

Updated: Oct 14, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	11.48M	—	—	Oct 14, 2025	—	Disposition	—	Oct 09	View
From 4	-0.00	156.00	$1.88	-$0.96	Aug 07, 2025	22.96M	Sale	—	Aug 05	View
From 3	—	—	—	—	Jul 21, 2022	8.56M	—	—	—	View

RAINrain oncology inc.

Updated: Jan 29, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	8.63M	—	—	Jan 29, 2024	—	Disposition	—	Jan 25 - 26	View
From 4	0.48	1.71M	$5.83	$9.97M	Nov 10, 2022	8.60M	Purchase	—	Nov 08	View
From 4	0.20	557.73K	$12.00	$6.69M	Jan 10, 2022	6.87M	Purchase	—	Jan 06 - 07	View
From 4	0.00	11.03K	$13.94	$153.83K	Sep 23, 2021	6.31M	Purchase	—	Sep 21	View
From 4	0.17	392.27K	$16.49	$6.47M	Sep 15, 2021	6.30M	Purchase	—	Sep 13	View
From 4	0.34	587.00K	$15.47	$9.08M	Jul 06, 2021	5.91M	Purchase	—	Jul 01 - 06	View
From 4	0.08	123.35K	$15.94	$1.97M	May 25, 2021	5.32M	Purchase	—	May 21 - 24	View
From 4	0.15	208.47K	$16.59	$3.46M	May 20, 2021	5.20M	Purchase	—	May 18 - 19	View
From 4	0.04	58.00K	$14.26	$827.17K	May 17, 2021	4.99M	Purchase	—	May 13	View
From 4/A	5.22	1.13M	$16.86	$19.10M	May 17, 2021	1.35M	Purchase	—	Apr 23 - 26	View
From 4	0.30	1.13M	$16.86	—	Apr 27, 2021	4.93M	Options	—	Apr 23 - 26	View
From 3	—	—	—	—	Apr 27, 2021	—	—	—	—	View

PVLApalvella therapeutics, inc.

Updated: Dec 17, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.73	438.93K	—	—	Dec 17, 2024	708.42K	Acquisition	—	Dec 13	View
From 3	—	—	—	—	May 22, 2023	20.33M	—	—	—	View
From 4	-0.01	50.00K	$4.50	-$224.97K	Sep 10, 2019	7.31M	Sale	—	Sep 06	View
From 3	—	—	—	—	Sep 10, 2019	4.98M	—	—	—	View
From 4	-0.72	5.00M	—	—	Feb 01, 2019	4.27M	Disposition	—	Jan 30	View
From 3	—	—	—	—	Nov 26, 2018	6.89M	—	—	—	View

ELDNeledon pharmaceuticals, inc.

Updated: Oct 31, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.49	4.75M	$3.65	$17.35M	Oct 31, 2024	27.25M	Purchase	—	Oct 29	View
From 4	1.83	7.86M	—	—	May 13, 2024	22.50M	Purchase	—	May 09	View
From 4	5.01	11.57M	—	—	May 09, 2023	14.64M	Purchase	—	May 05	View
From 3	—	—	—	—	Jan 31, 2022	2.31M	—	—	—	View
From 4	4.01	1.27M	—	—	Dec 28, 2020	1.74M	Options	—	Dec 22	View
From 3	—	—	—	—	Oct 05, 2020	193.93K	—	—	—	View

FDMT4d molecular therapeutics, inc.

Updated: Nov 13, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Nov 13, 2024	7.26M	Acq/Dis	—	Nov 08	View
From 3	—	—	—	—	Aug 01, 2024	7.26M	—	—	—	View
From 3	—	—	—	—	Jun 27, 2022	3.91M	—	—	—	View

THRDthird harmonic bio, inc.

Updated: Oct 31, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	1.00M	$14.30	-$14.30M	Oct 31, 2024	3.34M	Sale	—	Oct 29	View
From 4	0.05	214.06K	$4.11	$879.50K	Dec 22, 2022	4.34M	Purchase	—	Dec 20	View
From 3	—	—	—	—	Dec 22, 2022	4.12M	—	—	—	View

CGEMcullinan oncology, inc.

Updated: Jan 19, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.78	5.76M	—	—	Jan 19, 2023	1.66M	Disposition	—	Jan 19	View
From 4	0.11	751.40K	$11.00	$8.26M	Jun 03, 2022	7.42M	Purchase	—	Jun 01	View
From 4	0.20	1.11M	$9.09	$10.06M	May 16, 2022	6.66M	Purchase	—	May 12 - 13	View
From 4	0.06	276.00K	$10.75	$2.97M	Apr 05, 2022	5.55M	Purchase	—	Apr 01	View
From 3	—	—	—	—	Jan 10, 2022	5.28M	—	—	—	View

cti biopharma corp

Updated: Jun 28, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	9.33M	$9.10	-$80.59M	Jun 28, 2023	—	Disposition	—	Jun 26	View
From 4	—	80.00K	—	—	Apr 07, 2023	9.33M	Grant	—	Apr 05	View
From 4	-0.01	129.24K	$6.12	-$52.02M	Aug 11, 2022	9.25M	Sale	—	Aug 09	View
From 4	—	80.00K	—	—	Mar 11, 2022	9.38M	Grant	—	Mar 09	View
From 4	0.36	2.00M	$275.90	$5.08M	Apr 05, 2021	9.30M	Purchase	—	Apr 01	View
From 4	—	80.00K	—	—	Mar 12, 2021	7.30M	Grant	—	Mar 10	View
From 4	0.85	1.92K	—	—	Mar 04, 2020	6.95M	Purchase	—	Mar 02 - 04	View
From 4	-0.19	1.65M	$3.00	$19.00M	Feb 12, 2018	6.94M	Disposition	—	Feb 09	View
From 4	0.92	4.12M	—	—	Jun 14, 2017	8.60M	Purchase	—	Jun 09	View
From 4	0.01	1.00M	$1.22	$1.22M	Jan 11, 2016	72.02M	Purchase	—	Jan 07 - 08	View
From 3	—	—	—	—	Dec 14, 2015	43.80M	—	—	—	View

GPCRstructure therapeutics inc.

Updated: May 12, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	May 12, 2023	12.58M	Acq/Dis	—	May 10	View
From 3	—	—	—	—	Feb 13, 2023	12.58M	—	—	—	View

ENGNengene holdings inc.

Updated: Nov 13, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Nov 13, 2023	2.22M	—	—	—	View

PNTpoint biopharma global inc.

Updated: Dec 20, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	17.16M	$12.45	-$213.66M	Dec 20, 2023	—	Sale	—	Dec 18	View
From 3	—	—	—	—	Nov 06, 2023	17.16M	—	—	—	View

VSTMverastem, inc.

Updated: Feb 07, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Feb 07, 2022	19.63M	—	—	—	View

MRUSmerus n.v.

Updated: Oct 08, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.23	1.13M	$27.56	-$31.22M	Oct 08, 2021	3.84M	Sale	—	Oct 07 - 08	View
From 4	-0.31	2.19M	$20.75	-$45.36M	Jul 07, 2021	4.97M	Sale	—	Jul 02	View
From 4	0.04	300.00K	$19.75	$5.93M	Apr 01, 2021	7.16M	Purchase	—	Mar 30	View
From 4	0.02	79.50K	$22.75	$1.81M	Mar 24, 2021	6.86M	Purchase	—	Mar 22	View
From 4	0.04	250.00K	$23.00	$5.75M	Mar 18, 2021	6.78M	Purchase	—	Mar 16	View
From 4	0.15	844.68K	$24.75	$20.91M	Jan 25, 2021	6.53M	Purchase	—	Jan 21	View
From 4	0.03	160.00K	$16.05	$2.57M	Dec 22, 2020	5.68M	Purchase	—	Dec 18	View
From 4	0.03	146.75K	$11.75	$1.72M	Sep 17, 2020	5.52M	Purchase	—	Sep 15	View
From 4	0.04	189.65K	$11.10	$2.10M	Sep 14, 2020	5.38M	Purchase	—	Sep 10	View
From 4	0.04	201.91K	$11.17	$2.26M	Sep 08, 2020	5.19M	Purchase	—	Sep 03	View
From 4	0.02	87.25K	$15.20	$1.33M	Jun 10, 2020	4.99M	Purchase	—	Jun 08	View
From 4	0.43	1.46M	$14.00	$20.48M	Jun 03, 2020	4.90M	Purchase	—	Jun 01	View
From 4	0.09	278.73K	$16.15	$4.50M	Jan 21, 2020	3.44M	Purchase	—	Jan 16	View
From 4	0.03	83.96K	$14.98	$1.26M	Jan 15, 2020	3.16M	Purchase	—	Jan 13	View
From 3	—	—	—	—	Jan 13, 2020	3.07M	—	—	—	View

IDYAideaya biosciences, inc.

Updated: Feb 04, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.01	46.41K	$18.00	-$835.36K	Feb 04, 2021	3.06M	Sale	—	Feb 02	View
From 4	0.00	2.53K	$13.32	$33.70K	Jul 02, 2020	3.11M	Purchase	—	Jun 30	View
From 4	0.02	118.00K	$14.16	$1.69M	Jun 22, 2020	6.19M	Purchase	—	Jun 19 - 22	View
From 3	—	—	—	—	Jun 22, 2020	2.99M	—	—	—	View

CTMXcytomx therapeutics, inc.

Updated: Feb 18, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 18, 2021	5.47M	—	—	—	View
From 3	—	—	—	—	Dec 28, 2020	5.47M	—	—	—	View

INFIQinfinity pharmaceuticals, inc.

Updated: Feb 19, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Feb 19, 2021	8.26M	—	—	—	View
From 4	-0.21	2.26M	$5.37	-$12.13M	Feb 16, 2021	8.26M	Sale	—	Feb 11	View
From 4	-0.36	5.85M	$4.14	-$24.21M	Jan 26, 2021	10.52M	Sale	—	Jan 22	View
From 4	0.01	175.00K	$1.20	$209.91K	Dec 17, 2018	16.37M	Purchase	—	Dec 13	View
From 4	0.02	100.00K	$1.30	$130.00K	Nov 30, 2018	16.20M	Purchase	—	Nov 28	View
From 4	0.04	1.47M	$1.36	$2.01M	Nov 21, 2018	41.78M	Purchase	—	Nov 19 - 21	View
From 4	0.02	905.93K	$1.35	$1.22M	Nov 15, 2018	41.15M	Purchase	—	Nov 13 - 15	View
From 4	0.17	3.94M	$1.65	$6.50M	Jun 21, 2018	27.02M	Purchase	—	Jun 19 - 21	View
From 4	0.09	1.51M	$1.95	$2.97M	Apr 11, 2018	18.55M	Purchase	—	Apr 09 - 10	View
From 4	0.11	1.60M	$1.26	$2.01M	Oct 05, 2017	15.88M	Purchase	—	Oct 03 - 04	View
From 4	0.00	4.38K	$1.34	$5.87K	Jan 05, 2017	6.67M	Purchase	—	Jan 03	View
From 4	0.06	742.40K	$1.34	$991.57K	Dec 30, 2016	12.63M	Purchase	—	Dec 28 - 30	View
From 4	0.04	654.92K	$1.33	$855.49K	Dec 20, 2016	17.52M	Purchase	—	Dec 16 - 20	View
From 4	0.02	201.39K	$1.19	$238.85K	Dec 02, 2016	10.48M	Purchase	—	Dec 01 - 02	View
From 3	—	—	—	—	Dec 02, 2016	5.07M	—	—	—	View

five prime therapeutics, inc.

Updated: Mar 08, 2021

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Mar 08, 2021	6.26M	—	—	—	View
From 4	-0.86	7.39M	$20.19	-$149.25M	Nov 13, 2020	1.24M	Sale	—	Nov 11	View
From 4	0.05	446.56K	$4.89	$2.18M	Nov 06, 2020	8.63M	Purchase	—	Nov 04 - 06	View
From 4	0.04	345.24K	$5.04	$1.74M	Oct 08, 2020	8.18M	Purchase	—	Oct 06	View
From 4	0.00	32.00	$3.80	$121.56	Sep 24, 2020	7.84M	Purchase	—	Sep 22	View
From 4	0.04	293.59K	$4.10	$1.20M	May 18, 2020	7.84M	Purchase	—	May 14	View
From 4	0.07	515.02K	$4.05	$2.09M	Dec 26, 2019	7.55M	Purchase	—	Dec 20	View
From 4	0.02	135.00K	$4.02	$542.36K	Dec 11, 2019	7.03M	Purchase	—	Dec 09	View
From 4	0.19	1.12M	$3.40	$3.81M	Nov 26, 2019	6.90M	Purchase	—	Nov 22	View
From 4	0.20	968.11K	$4.00	$3.87M	Nov 07, 2019	5.78M	Purchase	—	Nov 05	View
From 4	0.00	29.31K	$3.88	$113.81K	Oct 31, 2019	14.39M	Purchase	—	Oct 29 - 31	View
From 4	0.02	169.37K	$3.75	$634.32K	Oct 25, 2019	9.53M	Purchase	—	Oct 23 - 25	View
From 4	0.05	601.48K	$3.72	$2.25M	Oct 08, 2019	13.18M	Purchase	—	Oct 04 - 08	View
From 3	—	—	—	—	Oct 02, 2019	4.01M	—	—	—	View

CYTKcytokinetics inc

Updated: Dec 11, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.06	430.95K	$18.00	-$7.76M	Dec 11, 2020	7.03M	Sale	—	Dec 09	View
From 3	—	—	—	—	Dec 04, 2020	7.47M	—	—	—	View
From 4	-1.00	1.38K	—	—	Nov 20, 2020	7.07M	Disposition	—	Nov 20	View
From 3	—	—	—	—	Nov 16, 2020	7.07M	—	—	—	View
From 4	-0.15	1.07M	$15.79	-$16.92M	Feb 18, 2020	5.91M	Sale	—	Feb 13	View
From 4	0.03	342.07K	$9.46	$3.23M	Dec 12, 2019	13.84M	Purchase	—	Dec 10 - 11	View
From 3	—	—	—	—	Dec 12, 2019	6.64M	—	—	—	View

CALAcalithera biosciences, inc.

Updated: May 26, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.25	2.28M	$6.00	-$13.70M	May 26, 2020	6.96M	Sale	—	May 21	View
From 4	0.02	191.95K	$3.91	$750.85K	Nov 22, 2019	9.24M	Purchase	—	Nov 20	View
From 4	0.01	128.49K	$3.37	$433.00K	Nov 18, 2019	9.05M	Purchase	—	Nov 14	View
From 4	0.16	2.40M	$2.65	$6.31M	Oct 31, 2019	17.05M	Purchase	—	Oct 29 - 30	View
From 3	—	—	—	—	Jul 01, 2019	6.53M	—	—	—	View

principia biopharma inc.

Updated: Aug 20, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.05	2.27K	$35.79	$81.17K	Aug 20, 2020	51.20K	Purchase	—	Aug 18	View
From 3	—	—	—	—	Aug 20, 2020	—	—	—	—	View

concert pharmaceuticals, inc.

Updated: Jun 12, 2019

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.14	386.29K	$10.70	-$4.13M	Jun 12, 2019	2.30M	Sale	—	Jun 10	View
From 3	—	—	—	—	Apr 02, 2019	2.69M	—	—	—	View
From 4	-0.43	1.28M	$26.65	-$34.19M	Dec 21, 2017	1.71M	Sale	—	Dec 19	View
From 4	0.12	331.92K	$15.84	$5.26M	Oct 23, 2017	2.99M	Purchase	—	Oct 19	View
From 3	—	—	—	—	Sep 29, 2017	2.66M	—	—	—	View

immune design corp.

Updated: Dec 04, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.16	902.00K	$1.83	-$1.65M	Dec 04, 2018	4.82M	Sale	—	Dec 04	View
From 3	—	—	—	—	Nov 09, 2018	5.72M	—	—	—	View

SNDXsyndax pharmaceuticals inc

Updated: Jun 20, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jun 20, 2018	2.90M	Acq/Dis	—	Jun 18	View
From 3	—	—	—	—	Dec 08, 2017	2.90M	—	—	—	View

arqule inc

Updated: Jun 01, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.11	1.04M	$5.00	-$5.18M	Jun 01, 2018	10.86M	Sale	—	May 30	View
From 4	-0.19	2.23M	$3.10	-$6.91M	Apr 20, 2018	11.90M	Sale	—	Apr 18	View
From 4	-0.16	2.30M	$2.90	-$6.67M	Apr 06, 2018	14.13M	Sale	—	Apr 04	View
From 3	—	—	—	—	Oct 20, 2017	14.21M	—	—	—	View

XENExenon pharmaceuticals inc.

Updated: Jun 30, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	0.03	85.46K	$3.04	$259.47K	Jun 30, 2017	2.99M	Purchase	—	Jun 27	View
From 3	—	—	—	—	Sep 12, 2016	2.50M	—	—	—	View

ALPNnivalis therapeutics, inc.

Updated: Jun 22, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	17.81K	$2.25	$40.06K	Jun 22, 2017	2.03M	Purchase	—	Jun 20	View
From 4	0.02	72.65K	$2.29	$166.07K	Jun 07, 2017	3.98M	Purchase	—	Jun 05 - 07	View
From 4	0.01	47.00K	$2.28	$106.53K	Jun 01, 2017	3.85M	Purchase	—	May 30 - 31	View
From 4	0.01	78.86K	$2.30	$181.32K	May 19, 2017	5.62M	Purchase	—	May 17 - 19	View
From 4	0.02	109.03K	$2.33	$253.43K	May 11, 2017	5.36M	Purchase	—	May 09 - 11	View
From 3	—	—	—	—	May 11, 2017	1.70M	—	—	—	View

RGLSregulus therapeutics inc.

Updated: Nov 27, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Nov 27, 2017	11.11M	—	—	—	View

cascadian therapeutics, inc.

Updated: Jun 27, 2016

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	17.25K	$800.00	$13.80M	Jun 27, 2016	23.83M	Grant	—	Jun 23	View
From 3	—	—	—	—	Dec 22, 2015	18.80M	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions